TMPRSS2 and prostate cancer: One of the most distinct features of prostate cancer is that more than half of the patients display gene fusion between androgen-responsive gene TMPRSS2 (transmembrane protease, serine 2) and ETS (erythroblast transformation-specific) transcription factor genes such as ERG (ETS-related gene) and ETV13.